Literature DB >> 21507981

NF-kappaB-mediated modulation of inducible nitric oxide synthase activity controls induction of the Epstein-Barr virus productive cycle by transforming growth factor beta 1.

Lassad Oussaief1, Vanessa Ramírez, Aurélie Hippocrate, Hratch Arbach, Chantal Cochet, Alexis Proust, Martine Raphaël, Ridha Khelifa, Irène Joab.   

Abstract

Transforming growth factor beta 1 (TGF-β1) signal transduction has been implicated in many second-messenger pathways, including the NF-κB pathway. We provide evidence of a novel TGF-β1-mediated pathway that leads to extracellular signal-regulated kinase (ERK) 1/2 phosphorylation, which in turn induces expression of an Epstein-Barr virus (EBV) protein, ZEBRA, that is responsible for the induction of the viral lytic cycle. This pathway includes two unexpected steps, both of which are required to control ERK 1/2 phosphorylation: first, a quick and transient activation of NF-κB, and second, downregulation of inducible nitric oxide synthase (iNOS) activity that requires the participation of NF-κB activity. Although necessary, NF-κB alone is not sufficient to produce downregulation of iNOS, suggesting that another uncharacterized event(s) is involved in this pathway. Dissection of the steps involved in the switch from the EBV latent cycle to the lytic cycle will be important to understand how virus-host relationships modulate the innate immune system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507981      PMCID: PMC3126544          DOI: 10.1128/JVI.02560-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

Review 1.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

Review 2.  Hostile takeovers: viral appropriation of the NF-kappaB pathway.

Authors:  J Hiscott; H Kwon; P Génin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

3.  The Epstein-Barr virus transactivator Zta binds to its own promoter and is required for full promoter activity during anti-Ig and TGF-beta1 mediated reactivation.

Authors:  Qinyan Yin; Kendra Jupiter; Erik K Flemington
Journal:  Virology       Date:  2004-09-15       Impact factor: 3.616

4.  EBV-associated neoplasms: alternative pathogenetic pathways.

Authors:  Hans Helmut Niller; Daniel Salamon; Karin Ilg; Anita Koroknai; Ferenc Banati; Fritz Schwarzmann; Hans Wolf; Janos Minarovits
Journal:  Med Hypotheses       Date:  2004       Impact factor: 1.538

5.  A novel IKKbeta inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance.

Authors:  Junji Kamon; Toshimasa Yamauchi; Susumu Muto; Sato Takekawa; Yusuke Ito; Yusuke Hada; Wataru Ogawa; Akiko Itai; Masato Kasuga; Kazuyuki Tobe; Takashi Kadowaki
Journal:  Biochem Biophys Res Commun       Date:  2004-10-08       Impact factor: 3.575

6.  Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury.

Authors:  Yasuyuki Onai; Jun-Ichi Suzuki; Tsunekazu Kakuta; Yasuhiro Maejima; Go Haraguchi; Hiroshi Fukasawa; Susumu Muto; Akiko Itai; Mitsuaki Isobe
Journal:  Cardiovasc Res       Date:  2004-07-01       Impact factor: 10.787

7.  Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines.

Authors:  Naohito Saito; Gilles Courtois; Ayako Chiba; Norio Yamamoto; Takeshi Nitta; Noriko Hironaka; Martin Rowe; Naoki Yamamoto; Shoji Yamaoka
Journal:  J Biol Chem       Date:  2003-09-10       Impact factor: 5.157

Review 8.  Epstein-Barr virus and cancer.

Authors:  Matthew P Thompson; Razelle Kurzrock
Journal:  Clin Cancer Res       Date:  2004-02-01       Impact factor: 12.531

9.  Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients.

Authors:  Yoshifumi Nagata; Hiroko Inoue; Koichi Yamada; Hiroyuki Higashiyama; Kenji Mishima; Yasuhiro Kizu; Ienaka Takeda; Fumio Mizuno; Yoshio Hayashi; Ichiro Saito
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

10.  The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites.

Authors:  G Urier; M Buisson; P Chambard; A Sergeant
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  9 in total

Review 1.  Regulation of the latent-lytic switch in Epstein-Barr virus.

Authors:  Shannon C Kenney; Janet E Mertz
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

2.  Protein kinase inhibitors that inhibit induction of lytic program and replication of Epstein-Barr virus.

Authors:  R Goswami; S Gershburg; A Satorius; E Gershburg
Journal:  Antiviral Res       Date:  2012-10-08       Impact factor: 5.970

3.  Protective role of propofol on the kidney during early unilateral ureteral obstruction through inhibition of epithelial-mesenchymal transition.

Authors:  Li Song; Sen Shi; Wei Jiang; Xueru Liu; Yanzheng He
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells.

Authors:  Dhananjay M Nawandar; Makoto Ohashi; Reza Djavadian; Elizabeth Barlow; Kathleen Makielski; Ahmed Ali; Denis Lee; Paul F Lambert; Eric Johannsen; Shannon C Kenney
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

5.  Inducible nitric oxide synthase (iNOS) regulatory region variation in non-human primates.

Authors:  Morteza Roodgar; Cody T Ross; Nicholas J Kenyon; Gretchen Marcelino; David Glenn Smith
Journal:  Infect Genet Evol       Date:  2015-02-09       Impact factor: 3.342

6.  Over-production of nitric oxide by oxidative stress-induced activation of the TGF-β1/PI3K/Akt pathway in mesangial cells cultured in high glucose.

Authors:  Yun-peng Zhai; Qian Lu; Yao-wu Liu; Qian Cheng; Ya-qin Wei; Fan Zhang; Cheng-lin Li; Xiao-xing Yin
Journal:  Acta Pharmacol Sin       Date:  2013-03-25       Impact factor: 6.150

7.  Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB-Controlled Oxidative Stress Responses.

Authors:  Yusuke Shono; Andrea Z Tuckett; Hsiou-Chi Liou; Ekaterina Doubrovina; Enrico Derenzini; Samedy Ouk; Jennifer J Tsai; Odette M Smith; Emily R Levy; Fabiana M Kreines; Carly G K Ziegler; Mary I Scallion; Mikhail Doubrovin; Glenn Heller; Anas Younes; Richard J O'Reilly; Marcel R M van den Brink; Johannes L Zakrzewski
Journal:  Cancer Res       Date:  2016-01-07       Impact factor: 12.701

8.  The epinephrine-induced PGE2 reduces Na+/K+ ATPase activity in Caco-2 cells via PKC, NF-κB and NO.

Authors:  Layla El Moussawi; Mohamed Chakkour; Sawsan Kreydiyyeh
Journal:  PLoS One       Date:  2019-08-08       Impact factor: 3.240

Review 9.  Molecular Mechanisms of H. pylori-Induced DNA Double-Strand Breaks.

Authors:  Dawit Kidane
Journal:  Int J Mol Sci       Date:  2018-09-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.